Haleon buys back £230m of its shares as Pfizer sells down stake
Pfizer has offloaded a £2.43billion stake in consumer health spin-out Haleon, which said it would buy back £230million of the shares. FTSE 100-listed Haleon, which makes Panadol painkillers and Sensodyne toothpaste, said it had bought the shares at 308p each.
Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million ...
Pfizer anticipates revenue growth, driven by oncology investments, M&A activities, and manufacturing optimization. See why ...
Pfizer withdraws OXBRYTA after post marketing studies showed that the risks of side effects were greater than the benefits.
Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...
Pfizer’s decision Wednesday to pull its sickle cell pill off the market because of safety concerns shocked advocates and ...
Although it has been plagued by multiple issues, including falling sales with lower demand for its Covid-19 products, and an ...
I.C. Stars has started a new, unique program in partnership with a nonprofit to help new mothers start careers in information ...
On Friday, Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $29.09 which represents a slight increase of $0.12 or 0.41% from the prior close of $28.97. The stock opened at $29.02 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback